Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nosa PlugsOSTO:NOSA -1.60%54 Receivables Turnover is 1.88 as of Mar. 2026. GuruFocus rates OSTO:NOSA with a GF Score™ of 54/100 and a GF Value™ of kr1.21 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Nosa Plugs ranks better than 82.37% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Nosa Plugs's Revenue for the
three
months ended in Mar. 2026 was kr8.19 Mil. Nosa Plugs's average Accounts Receivable for the
three
months ended in Mar. 2026 was kr4.35 Mil.
Hence, Nosa Plugs's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.88.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Nosa Plugs Receivables Turnover Related Terms
Nosa Plugs Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Nosa Plugs's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:NOSA vs ABT, SYK, MDT: Receivables Turnover Comparison
For the Medical Devices subindustry, Nosa Plugs's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nosa Plugs Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nosa Plugs's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Nosa Plugs's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nosa Plugs (OSTO:NOSA) has a Receivables Turnover of 1.88 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nosa Plugs and its competitors. According to the industry distribution chart, Nosa Plugs ranks #143 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 17.6%.
Is Nosa Plugs' Receivables Turnover too high?
Nosa Plugs' current Receivables Turnover is 1.88. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Nosa Plugs' value of 1.88 is 65.9% below this industry median. Based on the distribution chart, Nosa Plugs ranks #143 out of 811 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nosa Plugs has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nosa Plugs' Receivables Turnover compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nosa Plugs ranks #143 out of 811 companies for Receivables Turnover. This places Nosa Plugs in the top 18% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.51. Nosa Plugs' value of 1.88 is 65.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nosa Plugs's current Receivables Turnover of 1.88 is 65.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nosa Plugs and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nosa Plugs's current Receivables Turnover is 1.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nosa Plugs stock overvalued right now?
Based on GuruFocus' analysis, Nosa Plugs (OSTO:NOSA) is currently considered Possible Value Trap. The stock's GF Value™ is kr1.21, compared to a current price of kr0.49 — trading 59.4% below its estimated fair value. The current Receivables Turnover is 1.88 and 65.9% below the Medical Devices & Instruments industry median of 5.51. Nosa Plugs' overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Nosa Plugs (OSTO:NOSA), the current Receivables Turnover is 1.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nosa Plugs (OSTO:NOSA) Overvalued in 2026?
Based on GuruFocus' analysis, Nosa Plugs stock appears to be undervalued.
The current stock price of kr0.49 is trading 59.4% below its estimated GF Value™ of kr1.21.
GuruFocus considers Nosa Plugs to be Possible Value Trap.
Key valuation signals for OSTO:NOSA:
Receivables Turnover: 1.88
GF Value™: kr1.21 vs. price of kr0.49 (59.4% below fair value)
Industry Position: 65.9% below the Medical Devices & Instruments median (#143 of 811)
No single metric tells the full story. See the OSTO:NOSA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nosa Plugs is a Swedish medical technology company. It is a supplier of nasal protection and nasal filters. With the vision to improve the breathing experience for everyone, NOSA offers a product portfolio consisting of odor protection, nasal filters against allergens and nasal protection that reduces viruses and bacteria.
54GF Score
Get the complete analysis for OSTO:NOSA
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:NOSA has been successfully added to your 
